Education:
PhD (Pharmaceutical Sciences), Mercer University, 2009
MS (Microbiology - Immunology), Mahidol University, Thailand, 1991
BS (Medical Technology), Mahidol University, Thailand, 1991

Research focus:
Topical microbicides and biomedical interventions to HIV prevention

Publications:

• 1. Evaluating drug synergy of tenofovir and nanoparticle-based antiretroviral microbicides. Chaowanachan T, Krogstad E, Cameron B, Woodrow KA. (Manuscript in preparation)
• 2. Carrageenan-based gel retains anti-HIV-1 activity following vaginal application by HIV-infected Thai women enrolled in a phase I safety trial. Haaland RE, Chaowanachan T, Evans-Strickfaden, van de Wijgert JH, Kilmarx PH, Mclean CA, Hart CE. (Manuscript in preparation)
• 3. Infection with hepatitis C virus among HIV-infected pregnant women in Thailand. Jamieson DJ, Skunodom N, Chaowanachan T, Roongpisuthipong A, Bower WA, Chotpitayasunondh T, Bhanich Supapol W, Kuhnert WL, Siriwasin W, Wiener J, Chearskul S, McConnell MS, Shaffer N. Infect Dis Obstet Gynecol. 2008; 2008:840948. Epub 2009 Jan 27.
• 4. Cross-reactive T cell responses in HIV CRF01_AE and B'-infected intravenous drug users: implications for superinfection and vaccines. Promadej-Lanier N, Thielen C, Hu DJ, Chaowanachan T, Gvetadze R, Choopanya K, Vanichseni S, McNicholl JM. AIDS Res Hum Retroviruses. 2009 Jan; 25(1):73-81.
• 5. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003. Suntharasamai P, Martin M, Vanichseni S, van Griensven F, Mock PA, Pitisuttithum P, Tappero JW, Sangkum U, Kitayaporn D, Gurwith M, Choopanya K; Bangkok Vaccine Evaluation Group. Addiction. 2009 Feb;104(2):235-42.
• 6. Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. Leelawiwat W, Young NL, Chaowanachan T, Ou CY, Culnane M, Vanprapa N, Waranawat N, Wasinrapee P, Mock PA, Tappero J, McNicholl JM. J Virol Methods. 2009 Feb; 155(2):109-17. Epub 2008 Nov 18.
• 7. Increase in sexual risk behavior and prevalence of Chlamydia trachomatis among adolescents in Northern Thailand. Whitehead SJ, Leelawiwat W, Jeeyapant S, Chaikummao S, Papp J, Kilmarx PH, Markowitz LE, Tappero JW, Chaowanachan T, Uthaivoravit W, van Griensven F. Sex Transm Dis. 2008 Oct;35(10):883-8.
• 8. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand. Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J. Sex Transm Dis. 2008 Mar;35(3):226-32.
• 9. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization. Bollen LJ, Chuachoowong R, Kilmarx PH, Mock PA, Culnane M, Skunodom N, Chaowanachan T, Jetswang B, Neeyapun K, Asavapiriyanont S, Roongpisuthipong A, Wright TC, Tappero JW. Sex Transm Dis. 2006 Apr;33(4):259-64.
• 10. Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients. Pattanapanyasat K, Lerdwana S, Noulsri E, Chaowanachan T, Wasinrapee P, Sakulploy N, Pobkeeree V, Suksripanich O, Thanprasertsuk S, Spira TJ, Tappero JW, Levine WC. Clin Diagn Lab Immunol. 2005 Dec;12(12):1416-24.
• 11. HIV-1 subtyping using gag/env heteroduplex mobility assay and peptide enzyme-linked immunosorbent assay. Simparak W, Kositanont U, Sutthent R, Wasinrapee P, Chaowanachan T, Wasi C. Asian Pac J Allergy Immunol. 2005 Jun-Sep;23(2-3):143-52.
• 12. Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand. Hu DJ, Subbarao S, Vanichseni S, Mock PA, Ramos A, Nguyen L, Chaowanachan T, Griensven F, Choopanya K, Mastro TD, Tappero JW. AIDS. 2005 Feb 18;19(3):303-8.
• 13. Frequent human leukocyte antigen class I alleles are associated with higher viral load among HIV type 1 seroconverters in Thailand. Nguyen L, Chaowanachan T, Vanichseni S, McNicholl JM, Mock PA, Nelson R, Hodge TW, van Griensven F, Choopanya K, Mastro TD, Tappero JW, Hu DJ. J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1318-23.
• 14. CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users. Nguyen L, Li M, Chaowanachan T, Hu DJ, Vanichseni S, Mock PA, van Griensven F, Martin M, Sangkum U, Choopanya K, Tappero JW, Lal RB, Yang C. AIDS. 2004 Jun 18;18(9):1327-33.
• 15. Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials. Buchacz K, Hu DJ, Vanichseni S, Mock PA, Chaowanachan T, Srisuwanvilai LO, Gvetadze R, Van Griensven F, Tappero JW, Kitayaporn D, Kaewkungwal J, Choopanya K, Mastro TD. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):853-60.
• 16. Rapid whole-blood finger-stick test for HIV antibody: performance and acceptability among women in northern Thailand. Liu A, Kilmarx PH, Supawitkul S, Chaowanachan T, Yanpaisarn S, Chaikummao S, Limpakarnjanarat K. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):194-8.
• 17. Risk factors for sexually transmitted diseases in northern Thai adolescents: an audio-computer-assisted self-interview with noninvasive specimen collection. Paz-Bailey G, Kilmarx PH, Supawitkul S, Chaowanachan T, Jeeyapant S, Sternberg M, Markowitz L, Mastro TD, Van Griensven F. Sex Transm Dis. 2003 Apr;30(4):320-6.
• 18. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. Young NL, Shaffer N, Chaowanachan T, Chotpitayasunondh T, Vanparapar N, Mock PA, Waranawat N, Chokephaibulkit K, Chuachoowong R, Wasinrapee P, Mastro TD, Simonds RJ; Bangkok Collaborative Perinatal HIV Transmission Study Group. J Acquir Immune Defic Syndr. 2000 Aug 15; 24(5):401-7.
• 19. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group. Chuachoowong R, Shaffer N, Siriwasin W, Chaisilwattana P, Young NL, Mock PA, Chearskul S, Waranawat N, Chaowanachan T, Karon J, Simonds RJ, Mastro TD. J Infect Dis. 2000 Jan;181(1):99-106.
• 20. Clinical field site evaluation of the FACSCount for absolute CD3+, CD3+ CD4+, and CD3+ CD8+ cell count determinations in Thailand. Young NL, Ponglertnapakorn P, Shaffer N, Srisak K, Chaowanachan T, On-Thern V, Kittinunvorakoon C, Bunwattanakul A, Suksaweang S, Pobkeeree V, Punnotok J, Mastro TD. Clin Diagn Lab Immunol. 1997 Nov;4(6):783-6.
• 21. Modified amplicor HIV-1 polymerase chain reaction assay in Thailand. Young N, Shaffer N, Chaowanachan T, Rapier J, Kittinunvorakoon C, Suksaweang S, Rayfield M, Kalish ML, Mastro TD. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):391-2. No abstract available.
• 22. Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR. Respess RA, Butcher A, Wang H, Chaowanachan T, Young N, Shaffer N, Mastro TD, Biryahwaho B, Downing R, Tanuri A, Schechter M, Pascu R, Zekeng L, Kaptué L, Gürtler L, Eberle J, Ellenberger D, Fridlund C, Rayfield M, Kwok S. J Clin Microbiol. 1997 May;35(5):1284-6.
• 23. Production of monoclonal antibody specific to Campylobacter jejuni and its potential in diagnosis of Campylobacter enteritis. Chaiyaroj SC, Sirisereewan T, Jiamwatanasuk N, Sirisinha S. Asian Pac J Allergy Immunol. 1995 Jun;13(1):55-61.

Presentations:

• 1. T. Chaowanachan, E. Krogstad, C. Ball, and K.A. Woodrow, “Evaluating Drug Synergy of Tenofovir and Nanoparticle-based Antiretroviral Microbicides.” Poster presentation: International Microbicides Conference, Sydney, Australia, April 2012.
• 2. E. Krogstad, T. Chaowanachan, C. Ball, K.A. Woodrow, “Nanomaterials for Combination Chemo-prophylaxis against Sexual HIV Transmission.” Poster presentation: The 19th Conference on Retroviral and Opportunistic Infections, Seattle, WA, March 2012.
• 3. T. Chaowanachan, D.P. Do, B.S. Pai, M.J. D’Souza, “Development of Microparticles Containing the HIV-1 Entry Inhibitor Carrageenan for Prevention of HIV Transmission.” Poster presentation: Georgia Life Sciences Summit, Atlanta, GA, September 2008.
• 4. T. Chaowanachan, T. Chotpitayasunondh, N. Vanprapar, W. Leelawiwat, M. Culnane, B. Jetsawang, T. Tasaneeyapan, P. Mock, J. W. Tappero, RJ Simonds, “Resistance Mutations Following a Single-dose Intrapartum Administration of Nevirapine to HIV-infected Thai Women and Their Infants Receiving Short-course Zidovudine.” Poster presentation: The 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 2003.
• 5. T. Chaowanachan, K Chokephaibulkit, T Chotpitayasunondh, P Wasinrapee, A Teeraratkul, B Jetsawang, K Neeyapun, R.J. Simonds, N.L. Young, “Use of Dried Blood Spots for Diagnosis and Viral Quantification in Perinatal HIV-1 Infection in Thailand.” Oral presentation: The 14th International AIDS Conference, Barcelona, Spain, July 2002.
• 6. T. Chaowanachan, P. Wasinrapee, O. Suksripanich, S. Chaikummoa, J. Thongpun, P.H. Kilmarx, N.L. Young, “Do Topical Microbicides Impair the Accuracy of STD Testing?” Oral presentation: The 6th International Congress on AIDS in Asia and the Pacific, Melbourne, Australia, October 2001.

Honors and Awards:

• - CDC/ORISE – Fellowship, National Center for HIV, STD Prevention/ Laboratory Branch (NCHSTP/LB), Center for Disease Control and Prevention (CDC), Atlanta (2007 – 2009)
• - American Embassy Meritorious Honor Award for extended superior performance and extraordinary dedication to duty in providing management, leadership and technical expertise for the US CDC and the MOPH of Thailand (2004)
• - American Embassy Meritorious Honor Award for sustained excellent performance as a leader of laboratory research staff and extraordinary dedication to support many research studies of the US CDC and Thailand MOPH collaboration (1998)

Research focus:
Electrospun materials for drug delivery, contraception, and STI prevention.

Publications:

• 1. Ball, C., Krogstad, E., Chaowanachan, T.C., and Woodrow, K.A. Nanofibers for HIV-1 inhibition and contraception. In review.
• 2. Chaowanachan, T.C., Krogstad, E., Ball, C., and Woodrow, K.A. Drug synergy of tenofovir and nanoparticle-based antiretroviral drugs for prophylaxis. In preparation.
• 3. Lutz, B. R., Trinh, P., Ball, C., Fu, E. and Yager, P. Two-dimensional paper networks: programmable fluidic disconnects for multi-step processes in shaped paper. Lab on a Chip 11, 4274 (2011).

Presentations:

• 1. Drug-eluting nanofibers for multipurpose prevention of sexually transmited infections and unintended pregnancy, Ball, C., E. Krogstad and K.A. Woodrow, presented at International Microbicides Conference, Sydney, NSW, AU, 2012, oral presentation.
• 2. Evaluating drug synergy of tenofovir and nanoparticle-based antiretroviral microbicides, Chaowanachan, T., E. Krogstad, C. Ball, J. Phan and K.A. Woodrow, presented at International Microbicides Conference, Sydney, NSW, AU, 2012.
• 3. Nanomaterials for combination chemo-prophylaxis against sexual HIV transmission, Krogstad, E., T. Chaowanachan, C. Ball, J. Phan and K.A. Woodrow, presented at Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 2012.
• 4. Evaluating drug synergy of nanoparticle-based antiretroviral microbicides, Chaowanachan, T., E. Krogstad, C. Ball, J. Phan and K.A. Woodrow, presented at Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 2012.
• 5. Vaginal Matrices: nanofibers for dual prevention of HIV and unintended pregnancy, Ball, C., E. Krogstad and K. Woodrow, presented at CAMI Multipurpose Prevention Technologies Conference, Washington, DC, 2011, invited.
• 6. A self-referencing paper T-sensor for diffusion-based analyte detection, Osborn, J.L., L. Marshall, C. Holstein, C. Ball, B. Lutz, E. Fu and P. Yager, presented at MicroTAS, Seattle, WA, 2011.
• 7. Optimal drug loading in layered polymer matrix devices for controlled release of therapeutics, C. Ball, presented at 5th Pacific Coast Variational Conference, Seattle, WA 2011.
• 8. Noninvasive measurement of small bowel length, Ball, C., G. Booth and S. Chabra, presented at Washington University in St. Louis spring research symposium, St. Louis, MO, 2010.
• 9. Computational model of proteoglycan-rich extracellular matrix, Ball, C. and R.P. Mecham, presented at Washington University in St. Louis fall research symposium, St. Louis, MO, 2009.
• 10. Chemostat cultivation of possible hyperthermophilic methanotrophs from a great basin hot spring, Ball, C. and B.P. Hedlund, presented at UNLV summer research symposium, Las Vegas, NV, 2007.

Honors and Awards:

• NSF Graduate Research Fellowship (2012-current); NSF Graduate Research Fellowship - honorable mention (2011); All-USA College Academic Third Team (2010); Washington University Danforth Scholar (2006-2010); United States Presidential Scholar (2006); National Merit Scholar (2006); Member of Alpha Eta Mu Beta, Sigma Xi, and Tau Beta Pi honoraries.

Research focus:
Nanomaterials for vaginal delivery and combination HIV-1 prophylaxis.

Publications:

• 1. Ball, C.S., Krogstad, E., Chaowanachan, T.C., and Woodrow, K.A. Nanofibers for HIV-1 inhibition and contraception. In review.
• 2. Chaowanachan, T.C., Krogstad, E., Ball, C.S., and Woodrow, K.A. Drug synergy of tenofovir and nanoparticle-based antiretroviral drugs for prophylaxis. In preparation.
• 3. Tang, R., Palumbo, N., Nagarajan, L., Krogstad, E., Wang, C. Well-defined block copolymers for gene delivery to dendritic cells. Journal of Controlled Release 142(2): March 2010, p. 229-237.

Presentations:

• 1. T. Chaowanachan, E. Krogstad, C. Ball, and K.A. Woodrow. "Evaluating drug synergy of tenofovir and nanoparticle-based antiretroviral microbicides." Biomedical Engineering Society Annual Meeting, Atlanta, GA, October 2012.
• 2. C. Ball, E. Krogstad, K.A. Woodrow, "Drug-eluting nanofibers for multipurpose prevention of sexually transmited infections and unintended pregnancy." International Microbicides Conference, Sydney, Australia, April 2012.
• 3. T. Chaowanachan, E. Krogstad, C. Ball, and K.A. Woodrow, "Evaluating drug synergy of tenofovir and nanoparticle-based antiretroviral microbicides." International Microbicides Conference, Sydney, Australia, April 2012.
• 4. E. Krogstad, T. Chaowanachan, C. Ball, K.A. Woodrow, "Nanomaterials for combination chemo-prophylaxis against sexual HIV transmission." Conference on Retroviral and Opportunistic Infections, Seattle, WA, March 2012.
• 5. C. Ball, E. Krogstad, K.A. Woodrow, "Vaginal matrices: nanofibers preventing HIV and unintended pregnancy." CAMI Multipurpose Prevention Technologies Conference, Washington, D.C., November 2011.
• 6. C. Baker, J. Hegrenes, E. Krogstad, J. Pham, C. Rustad, "Aortic Technology intraoperative aortic clamp: introducing the AorTech Vulcan." University of Minnesota Biomedical Senior Design Show, May 2009.
• 7. E. Krogstad, "Engineering Hyaluronic Acid Hydrogels for Cardiac Tissue Repair." National Conference for Undergraduate Research (oral presentation), Salisbury, MD, April 2008.

Honors and Awards:

• National Science Foundation Graduate Fellowship (2012—current); Science Communications Fellow in Global Health, Pacific Science Center (2011-current); Summa cum laude honors, University of Minnesota (2009); Frank Louk Scholarship, University of Minnesota (2007—2009); Lynn Otten Scholarship, University of Minnesota (2007—2009); Presidential Scholarship, University of Minnesota (2005—2009).

Research focus:
Thermoresponsive nanoparticle systems for rapid, high sensitivity HIV detection.

Publications:

Presentations:

• 1. KL Viola, S Sharma, J Lin, S Gutiontov, J Phan, et al. "Possibilities for molecular diagnostic therapy in Alzheimer's disease through Aβ oligomer-selective antibodies conjugated to theranostic nanostructures." Society for Neuroscience, Chicago, IL. October 2009.
• 2. J Phan, Z Li, T Deming. "Synthesis of Well-Defined Polypeptide Brushes." UCLA NanoCER REU, Los Angeles, CA, 2008.
• 3. J Phan, A Lee, C White, M McNallan. "Growth Rates of Carbide Derived Carbon on Ti 3 SiC 2 ". IMSAloqium, Aurora, IL, May 2004.

Honors and Awards:

• National Science Foundation Graduate Fellowship (2010—current); Cum laude honors, Northwestern University (2009).

Research focus:
Nanomaterials for vaginal delivery and combination HIV-1 prophylaxis.

Publications:

• Ramanathan, R., Mahadevan, R., and Woodrow, K.A. Biophysical characterization of hydrogel-core lipid-shell nanolipogels for HIV chemoprophylaxis. In preparation.
• 2. von Maltzahn, G., Centrone, A., Park, J.H., Ramanathan, R., Sailor, M.J., Hatton, A., and Bhatia, S.N. SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely-Multiplexed Near-Infrared Imaging and Photothermal Therapy. Advanced Materials, 21: 1-6, 2009.
• 3. Cheng, H., Kastrup, C.J., Ramanathan, R., Siegwart, D.J., Ma, M.L., Bogatyrev, S.R., Xu, Q., Whitehead, K.A., Langer, R., Anderson, D.J. "Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery" ACS Nano, 2010 4 (2), 625-631.

Presentations:

• 1. D. Krishnaswamy, R. Ramanathan, A. Qamar, "Collaborative Wireless Nanobots for Tumor Discovery and Drug Delivery." IEEE Molecular and Nano Communications (MONACOM), Ottawa, Canada, June 2012.
• 2. R. Ramanathan, R. Mahadevan, M. Iadanza, T. Chaowanachan, "Biophysical characterization of hydrogel-core, lipid-shell nanolipogels for HIV chemoprophylaxis." International Microbicides Conference, Sydney, Australia, April 2012.

Honors and Awards: